Skip to main content

Becton Dickinson Increases Dividend

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The board of directors of Becton Dickinson have declared a quarterly dividend of $.41 per common share.

The firm will pay the dividend on Dec. 31, to shareholders of record on Dec. 10. The dividend is $.04 higher than the previous quarter. The indicated annual dividend for fiscal-year 2011 would be $1.64 per share, according to the firm.

Edward Ludwig, BD's chairman and CEO, noted that it will mark the 38th consecutive year in which BD has increased its dividend.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.